| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 259.74B | 249.53B | 229.86B | 236.24B | 228.59B | 220.45B |
| Gross Profit | 92.86B | 83.24B | 71.02B | 75.60B | 73.36B | 69.77B |
| EBITDA | 20.10B | 18.14B | 13.29B | 16.41B | 16.11B | 14.73B |
| Net Income | 9.40B | 8.13B | 6.36B | 7.24B | 7.01B | 7.05B |
Balance Sheet | ||||||
| Total Assets | 223.23B | 228.17B | 194.95B | 194.33B | 189.91B | 187.91B |
| Cash, Cash Equivalents and Short-Term Investments | 31.13B | 31.29B | 31.30B | 24.57B | 24.80B | 38.94B |
| Total Debt | 34.56B | 37.82B | 9.32B | 12.19B | 10.76B | 12.66B |
| Total Liabilities | 91.43B | 96.20B | 65.79B | 67.36B | 67.02B | 64.08B |
| Stockholders Equity | 131.41B | 131.81B | 128.84B | 126.62B | 122.55B | 123.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.98B | 5.28B | 3.50B | -588.00M | 13.17B |
| Operating Cash Flow | 0.00 | 3.94B | 14.43B | 10.69B | 5.71B | 17.16B |
| Investing Cash Flow | 0.00 | -18.02B | -449.00M | -7.65B | -7.71B | -6.08B |
| Financing Cash Flow | 0.00 | 13.97B | -7.41B | -3.50B | -12.30B | -309.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥123.92B | 6.21 | 7.75% | 3.63% | 17.43% | 248.12% | |
71 Outperform | ¥326.97B | 8.84 | ― | 1.35% | 15.92% | 52.76% | |
67 Neutral | ¥2.21B | 4.49 | ― | 1.92% | 11.96% | 30.75% | |
66 Neutral | ¥295.29B | 14.98 | 11.17% | 2.61% | 5.63% | 25.64% | |
64 Neutral | ¥449.62B | 9.24 | 4.18% | 2.57% | 1.26% | 14.65% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥249.34B | 19.39 | ― | 2.72% | 2.23% | 57.10% |